| Identification | |
| Name: | Retigabine Dihydrochloride |
| Synonyms: | Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamatedihydrochloride;N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester dihydrochloride; |
| CAS: | 150812-13-8 |
| Molecular Formula: | C16H18FN3O2.2HCl |
| Molecular Weight: | 376.2533 |
| InChI: | InChI=1/C16H18FN3O2.ClH/c1-2-22-16(21)20-15-8-7-13(9-14(15)18)19-10-11-3-5-12(17)6-4-11;/h3-9,19H,2,10,18H2,1H3,(H,20,21);1H |
| Molecular Structure: | ![(C16H18FN3O2.2HCl) Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamatedihydrochloride;N-(2-Amino-4-(4-fluo...](https://img1.guidechem.com/chem/e/dict/210/150812-13-8.jpg) |
| Properties | |
| Appearance: | Off-White Powder |
| Specification: |
Retigabine Dihydrochloride , with CAS number of 150812-13-8, can be called carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester, hydrochloride (1:2) ; Ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate dihydrochloride . It is an off-White Powder, used as a new experimental anticonvulsant drug. Anxiolytic. |
| Usage: | A new experimental anticonvulsant drug. Anxiolytic. |
| Safety Data | |
 |
|
